By Route of Administration, Injectables Remain the Backbone Through 2035 Injectable formulations account for nearly 99% of obesity GLP-1 therapy use in 2025, reflecting their status as the established delivery route for both semaglutide and tirzepatide
Retatrutide is an investigational single-peptide compound designed to activate three metabolic hormone receptors: GIP, GLP-1, and glucagon
Modulation of the stress hormone system reduces the physiological arousal that underlies anxious feelings
In human tissues, the ghrelin receptor mRNA has been detected in the normal anterior pituitary gland, pituitary adenoma, hypothalamus, and hippocampus
GHK-Cu has the broadest base, with several decades of dermal, scalp and cosmetic-research publications, and a reasonable foundation in connective-tissue biology
Melanotan 1 vs Melanotan 2: Whats the Real Difference